Docetero 80mg Injection (Docetaxel)

Docetero 80mg Injection is an anticancer medicine. It is prescribed to treat certain types of cancer such as breast cancer, non-small cell lung cancer, prostate cancer and cancers of head and neck. It contains Docetaxel as an active ingredient. It works by interfering with the microtubule structures to control the division and multiplication of the cancer cells. It should be given by healthcare professional only do not self administer this injection.

Lung, prostate, bladder, ovarian, breast, head and neck cancer

Most side effects caused by taking the Docetero 80mg Injection(Docetaxel 80mg) do not require medical attention and usually disappear as your body adjusts to the medicine. Immediately consult your doctor if they don't go away or cause more severe side effects after taking the Docetero 80mg Injection.
Common side effects include:
● Low blood platelets
● Hair loss
● Nerve damage
● Neuropathy
● Numbness of extremity
● Taste change
● Breathlessness
● Constipation
● Edema (swelling)
● Infection
● Loss of appetite
● Muscle pain
● Nail disorder
● Pain
● Weakness

Dosage and duration with Docetero 80mg Injection(Docetaxel 80mg) are determined by the doctor as per the stage & type of cancer and overall health condition of the patient. This injection should be given intravenously by a doctor or experienced nurse. Don't self- administer the injection and don't double the dose to compensate for the missed dose.

● Cortes, J. E., & Pazdur, R. (1995). Docetaxel. Journal of Clinical Oncology, 13(10), 2643-2655.
● Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M. S., & von Minckwitz, G. (2009). Docetaxel-related side effects and their management. European journal of oncology nursing, 13(1), 49-59.
● Clarke, S. J., & Rivory, L. P. (1999). Clinical pharmacokinetics of docetaxel. Clinical pharmacokinetics, 36(2), 99-114.
● Lyseng-Williamson, K. A., & Fenton, C. (2005). Docetaxel: a review of its use in metastatic breast cancer. Drugs, 65(17), 2513-2531.
● Montero, A., Fossella, F., Hortobagyi, G., & Valero, V. (2005). Docetaxel for treatment of solid tumours: a systematic review of clinical data. The lancet oncology, 6(4), 229-239.
● Baker, S. D., Sparreboom, A., & Verweij, J. (2006). Clinical pharmacokinetics of docetaxel: recent developments. Clinical pharmacokinetics, 45(3), 235-252.